Zhang, Y.; Chen, H.; Lv, J.; Huang, T.; Zhang, R.; Zhang, D.; Luo, L.; Wei, S.; Liu, X.; Zhang, S.;
et al. Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus. Vaccines 2022, 10, 1020.
https://doi.org/10.3390/vaccines10071020
AMA Style
Zhang Y, Chen H, Lv J, Huang T, Zhang R, Zhang D, Luo L, Wei S, Liu X, Zhang S,
et al. Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus. Vaccines. 2022; 10(7):1020.
https://doi.org/10.3390/vaccines10071020
Chicago/Turabian Style
Zhang, Yuntao, Haiping Chen, Jun Lv, Tao Huang, Ruizhi Zhang, Dongjuan Zhang, Linyun Luo, Sheng Wei, Xiaoqin Liu, Shangxiao Zhang,
and et al. 2022. "Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus" Vaccines 10, no. 7: 1020.
https://doi.org/10.3390/vaccines10071020
APA Style
Zhang, Y., Chen, H., Lv, J., Huang, T., Zhang, R., Zhang, D., Luo, L., Wei, S., Liu, X., Zhang, S., Mu, Q., Huang, R., Huang, J., Xiao, Y., Yang, Y., Han, Y., Gong, H., Guan, Q., Xie, F.,
... Yang, X.
(2022). Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus. Vaccines, 10(7), 1020.
https://doi.org/10.3390/vaccines10071020
